HOXB5 cooperates with NKX2-1 in the transcription of human RET

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Zhu, Jiang ^a   Garcia Barcelo, Maria Mercedes ^a   Tam, Paul Kwong Hang ^a   Lui, Vincent Chi Hang ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CIS ACTING ELEMENT; PROTEIN TYROSINE KINASE; TRANS ACTING FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXB5; TRANSCRIPTION FACTOR NKX2.1; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PHOX2B; TRANSCRIPTION FACTOR SOX10; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; HOXB5 PROTEIN, HUMAN; NUCLEAR PROTEIN; PROTEIN RET; RET PROTEIN, HUMAN; SMALL INTERFERING RNA; THYROID NUCLEAR FACTOR 1;

ARTICLE; BINDING SITE; COMPLEX FORMATION; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSACTIVATION; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; GENETIC TRANSCRIPTION; GENETICS; HIRSCHSPRUNG DISEASE; INTESTINE INNERVATION; METABOLISM; MOLECULAR GENETICS; PHENOTYPE; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; ENTERIC NERVOUS SYSTEM; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HIRSCHSPRUNG DISEASE; HOMEODOMAIN PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PHENOTYPE; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-RET; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 79958046096     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020815     Document Type: Article

References (36)

1. Heanue TA, Pachnis V, (2007) Enteric nervous system development and Hirschsprung's disease: advances in genetic and stem cell studies. Nat Rev Neurosci 8: 466-479.
2. Amiel J, Sproat-Emison E, Garcia-Barcelo M, Lantieri F, Burzynski G, et al. (2008) Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet 45: 1-14.
3. Iwashita T, Kruger GM, Pardal R, Kiel MJ, Morrison SJ, (2003) Hirschsprung disease is linked to defects in neural crest stem cell function. Science 301: 972-976.
4. Natarajan D, Marcos-Gutierrez C, Pachnis V, de Graaff E, (2002) Requirement of signalling by receptor tyrosine kinase RET for the directed migration of enteric nervous system progenitor cells during mammalian embryogenesis. Development 129: 5151-5160.
5. Pachnis V, Durbec P, Taraviras S, Grigoriou M, Natarajan D, (1998) III. Role Of the RET signal transduction pathway in development of the mammalian enteric nervous system. Am J Physiol 275: G183-186.
6. Schuchardt A, D'Agati V, Larsson-Blomberg L, Costantini F, Pachnis V, (1994) Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367: 380-383.
7. Angrist M, Kauffman E, Slaugenhaupt SA, Matise TC, Puffenberger EG, et al. (1993) A gene for Hirschsprung disease (megacolon) in the pericentromeric region of human chromosome 10. Nat Genet 4: 351-356.
8. Edery P, Lyonnet S, Mulligan LM, Pelet A, Dow E, et al. (1994) Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature 367: 378-380.
9. Lui VC, Leon TY, Garcia-Barcelo MM, Ganster RW, Chen BL, et al. (2005) Novel RET mutation produces a truncated RET receptor lacking the intracellular signaling domain in a 3-generation family with Hirschsprung disease. Clin Chem 51: 1552-1554.
10. Romeo G, Ronchetto P, Luo Y, Barone V, Seri M, et al. (1994) Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 367: 377-378.
11. Tam PK, Garcia-Barcelo M, (2004) Molecular genetics of Hirschsprung's disease. Semin Pediatr Surg 13: 236-248.
12. Tam PK, Garcia-Barcelo M, (2009) Genetic basis of Hirschsprung's disease. Pediatr Surg Int 25: 543-558.
13. Garcia-Barcelo M, Ganster RW, Lui VC, Leon TY, So MT, et al. (2005) TTF-1 and RET promoter SNPs: regulation of RET transcription in Hirschsprung's disease. Hum Mol Genet 14: 191-204.
14. Garcia-Barcelo MM, Lau DK, Ngan ES, Leon TY, Liu T, et al. (2007) Evaluation of the thyroid transcription factor-1 gene (TITF1) as a Hirschsprung's disease locus. Ann Hum Genet 71: 746-754.
15. Lang D, Chen F, Milewski R, Li J, Lu MM, et al. (2000) Pax3 is required for enteric ganglia formation and functions with Sox10 to modulate expression of c-ret. J Clin Invest 106: 963-971.
16. Lang D, Epstein JA, (2003) Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer. Hum Mol Genet 12: 937-945.
17. Emison ES, Garcia-Barcelo M, Grice EA Lantieri F, Amiel J, et al. (2010) Differential contributions of rare and common, coding and noncoding Ret mutations to multifactorial Hirschsprung disease liability. Am J Hum Genet 87: 60-74.
18. Miao X, Leon TY, Ngan ES, So MT, Yuan ZW, et al. (2010) Reduced RET expression in gut tissue of individuals carrying risk alleles of Hirschsprung's disease. Hum Mol Genet 19: 1461-1467.
19. Fu M, Lui VC, Sham MH, Cheung AN, Tam PK, (2003) HOXB5 expression is spatially and temporarily regulated in human embryonic gut during neural crest cell colonization and differentiation of enteric neuroblasts. Dev Dyn 228: 1-10.
20. Kuratani SC, Wall NA, (1992) Expression of Hox 2.1 protein in restricted populations of neural crest cells and pharyngeal ectoderm. Dev Dyn 195: 15-28.
21. Pitera JE, Smith VV, Thorogood P, Milla PJ, (1999) Coordinated expression of 3′ hox genes during murine embryonal gut development: an enteric Hox code. Gastroenterology 117: 1339-1351.
22. Wall NA, Jones CM, Hogan BL, Wright CV, (1992) Expression and modification of Hox 2.1 protein in mouse embryos. Mech Dev 37: 111-120.
23. Lui VC, Cheng WW, Leon TY Lau DK, Garcia-Barcelo MM, et al. (2008) Perturbation of hoxb5 signaling in vagal neural crests down-regulates ret leading to intestinal hypoganglionosis in mice. Gastroenterology 134: 1104-1115.
24. Garcia-Barcelo MM, Miao X, Lui VC, So MT, Ngan ES, et al. (2007) Correlation between genetic variations in Hox clusters and Hirschsprung's disease. Ann Hum Genet 71: 526-536.
25. Leon TY, Ngan ES, Poon HC, So MT, Lui VC, et al. (2009) Transcriptional regulation of RET by Nkx2-1, Phox2b, Sox10, and Pax3. J Pediatr Surg 44: 1904-1912.
26. Andrew SD, Delhanty PJ, Mulligan LM, Robinson BG, (2000) Sp1 and Sp3 transactivate the RET proto-oncogene promoter. Gene 256: 283-291.
27. Lim CY, Santoso B, Boulay T, Dong E, Ohler U, et al. (2004) The MTE, a new core promoter element for transcription by RNA polymerase II. Genes Dev 18: 1606-1617.
28. Smale ST, Kadonaga JT, (2003) The RNA polymerase II core promoter. Annu Rev Biochem 72: 449-479.
29. Fitze G, Appelt H, Konig IR, Gorgens H, Stein U, et al. (2003) Functional haplotypes of the RET proto-oncogene promoter are associated with Hirschsprung disease (HSCR). Hum Mol Genet 12: 3207-3214.
30. Griseri P, Bachetti T, Puppo F, Lantieri F, Ravazzolo R, et al. (2005) A common haplotype at the 5′ end of the RET proto-oncogene, overrepresented in Hirschsprung patients, is associated with reduced gene expression. Hum Mutat 25: 189-195.
31. Sancandi M, Griseri P, Pesce B, Patrone G, Puppo F, et al. (2003) Single nucleotide polymorphic alleles in the 5′ region of the RET proto-oncogene define a risk haplotype in Hirschsprung's disease. J Med Genet 40: 714-718.
32. Harvey RP, (1996) NK-2 homeobox genes and heart development. Dev Biol 178: 203-216.
33. De Felice M, Damante G, Zannini M, Francis-Lang H, Di Lauro R, (1995) Redundant domains contribute to the transcriptional activity of the thyroid transcription factor 1. J Biol Chem 270: 26649-26656.
34. Pachnis V, Mankoo B, Costantini F, (1993) Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119: 1005-1017.
35. Griseri P, Patrone G, Puppo F, Romeo G, Ravazzolo R, et al. (2003) Rescue of human RET gene expression by sodium butyrate: a novel powerful tool for molecular studies in Hirschsprung disease. Gut 52: 1154-1158.
36. Puppo F, Griseri P, Fanelli M, Schena F, Romeo G, et al. (2002) Cell-line specific chromatin acetylation at the Sox10-Pax3 enhancer site modulates the RET proto-oncogene expression. FEBS Lett 523: 123-127.